NASDAQ: KRYS - Krystal Biotech, Inc.

Altı ay boyunca karlılık: -8.7%
Temettü getirisi: 0.00%
Sektör: Healthcare

Promosyon programı Krystal Biotech, Inc.

Gelişmiş program Basit grafik
Financial Markets by TradingView

Şirket hakkında Krystal Biotech, Inc.

Krystal Biotech, Inc., биотехнологическая компания клинической стадии, занимается генной терапией повторного применения для лечения серьезных редких заболеваний в Соединенных Штатах. Его ведущим продуктом-кандидатом является беремаген геперпавек (B-VEC), который находится в фазе III клинических исследований по лечению дистрофического буллезного эпидермолиза.

daha fazla ayrıntı
Компания также участвует в разработке препарата KB105, который находится в стадии I/II клинических исследований для лечения пациентов с дефицитным аутосомно-рецессивным врожденным ихтиозом; KB301, который находится на клинической стадии фазы I/II для лечения морщин и других проявлений стареющей или поврежденной кожи; KB407, который находится на доклинической стадии муковисцидоза; и KB104, который находится на доклинической стадии для синдрома Нетертона. Его кандидаты на продукты на стадии открытия включают KB5xx для лечения хронических кожных заболеваний, KB3xx для лечения эстетических состояний кожи и продукт KB3xx. Krystal Biotech, Inc. была основана в 2015 году и имеет штаб-квартиру в Питтсбурге, штат Пенсильвания.
Karşılaştırma listesine ekle
İzleme listesine ekle
Portföye ekle
Fiyat bildirimi ekle

IPO date 2017-09-20
ISIN US5011471027
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт https://www.krystalbio.com
Цена ао 177.37
Günlük fiyat değişimi: 0% (177.37)
Haftalık fiyat değişimi: -1.43% (179.935)
Aylık fiyat değişimi: +17.22% (151.32)
3 ayda fiyat değişimi: +8.39% (163.64)
Altı ayda fiyat değişimi: -8.7% (194.27)
Yıllık fiyat değişimi: +2.54% (172.98)
3 yılda fiyat değişimi: +192.3% (60.68)
5 yılda fiyat değişimi: +182.89% (62.7)
10 yılda fiyat değişimi: 0% (177.37)
Yılbaşından bu yana fiyat değişimi: +13.22% (156.66)
Tüm parametreler

Hafife alma

İsim Anlam Seviye
P/S 16.36 1
P/BV 5.02 3
P/E 53.3 2
EV/EBITDA 40.17 1
Toplam: 4.13

Yeterlik

İsim Anlam Seviye
ROA, % 9.51 3
ROE, % 10.34 4
Toplam: 4.83

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0

Görev

İsim Anlam Seviye
Debt/EBITDA 0.0661 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 28951.5 10
karlılık Ebitda, % -462.54 0
karlılık EPS, % -275.1 0
Toplam: 2
Daha fazla ayrıntı

İşlem tarihi Açıklama tarihi İçeriden bilgi Tip Fiyat Hacim Miktar Şuna kadar paylaş:, % Şu tarihten sonra paylaş:, % Belge
28.02.2025 28.02.2025 Krishnan Krish S
President and CEO		 Satın almak 178.55 5 356 500 30000 0 0.12 bağlantı
28.02.2025 28.02.2025 Krishnan Krish S
President and CEO		 Satın almak 178.55 8 481 120 47500 0 0.19 bağlantı
28.02.2025 28.02.2025 Krishnan Suma
President, R&D		 Satın almak 178.55 8 481 120 47500 0 0.19 bağlantı
11.06.2024 11.06.2024 Krishnan Krish S
President and CEO		 Satış 175.76 4 394 000 25000 0 -0.1 bağlantı
11.06.2024 11.06.2024 Krishnan Suma
President, R&D		 Satış 175.77 4 394 250 25000 0 -0.1 bağlantı
28.02.2024 01.03.2024 Krishnan Krish S
President and CEO		 Satın almak 168.66 1 264 950 7500 0 0.03 bağlantı
28.02.2024 01.03.2024 Krishnan Krish S
President and CEO		 Satın almak 168.66 2 108 250 12500 0 0.05 bağlantı
28.02.2024 01.03.2024 Krishnan Suma
President, R&D		 Satın almak 168.66 2 108 250 12500 0 0.05 bağlantı
28.02.2024 01.03.2024 Krishnan Suma
President, R&D		 Satın almak 168.66 1 264 950 7500 0 0.03 bağlantı
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer		 Satış 166.05 1 245 380 7500 0 -0.03 bağlantı
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer		 Satın almak 63.55 476 625 7500 0 0.03 bağlantı
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer		 Satış 165.88 829 400 5000 0 -0.02 bağlantı
28.02.2024 01.03.2024 Romano Kathryn
Chief Accounting Officer		 Satın almak 31.77 317 700 10000 0 0.04 bağlantı
09.06.2023 09.06.2023 ORTH ANDREW C.
Chief Commercial Officer		 Satış 128.61 1 607 620 12500 0 -0.05 bağlantı
09.06.2023 09.06.2023 ORTH ANDREW C.
Chief Commercial Officer		 Satın almak 63.55 794 375 12500 0 0.05 bağlantı
09.06.2023 09.06.2023 JANNEY DANIEL
Director		 Satış 128.77 2 438 260 18935 0 -0.08 bağlantı
08.06.2023 09.06.2023 JANNEY DANIEL
Director		 Satış 128.11 3 979 740 31065 0 -0.12 bağlantı

Kurumlar Hacim Paylaşmak, %
Avoro Capital Advisors LLC 2565555 9
Vanguard Group Inc 2435774 8.54
FMR, LLC 2385898 8.37
Blackrock Inc. 1809547 6.35
Redmile Group, LLC 1733189 6.08
State Street Corporation 1237497 4.34
Frazier Life Sciences Management, L.P. 988460 3.47
Jennison Associates LLC 724344 2.54
Lord, Abbett & Co. LLC 618458 2.17
Dimensional Fund Advisors LP 550806 1.93

ETF Paylaşmak, % Yıllık karlılık, % Temettüler, %
Franklin Genomic Advancements Fund Franklin Genomic Advancements Fund 4.53775 1.54 0.22433
Invesco S&P SmallCap Health Care ETF 3.24661 10.25 0.41696
Jacob Forward ETF 2.70262 43.03 0.15284
Invesco Dorsey Wright Healthcare Momentum ETF 1.8811 6.18 0.12263
Virtus LifeSci Biotech Products ETF 1.46245 36.79 0.13953
AlphaMark Actively Managed Small Cap ETF 0.92564 41.15 1.74611
Direxion Daily S&P Biotech Bull 3x Shares 0.64346 4067.92 0.25924
Invesco Dorsey Wright SmallCap Momentum ETF 0.57748 33.91 0.61241
First Trust Small Cap Growth AlphaDEX Fund 0.56792 42.5 1.22182
First Trust Nasdaq Pharmaceuticals ETF 0.54366 18.37 2.19901
Northern Lights Fund Trust IV 0.53119 42.1 0.49246
Future Tech ETF 0.51487 426.34 0.8416
Principal Healthcare Innovators ETF 0.51487 618.5 0.8416
Invesco Nasdaq Biotechnology ETF 0.50883 28.58 0.8565
Vanguard S&P Small-Cap 600 Growth ETF 0.5 30.31 1.37064
SPDR S&P 600 Small Cap Growth ETF 0.46611 14.13 1.33495
John Hancock Multifactor Small Cap ETF 0.44188 16.88 1.54912
Vanguard S&P Small-Cap 600 ETF 0.37 13.46 1.89226
Vanguard Russell 2000 Growth ETF 0.36 23.05 0.60264
SPDR Portfolio S&P 600 Small Cap ETF 0.34897 13.05 1.84119
ProShares Ultra Nasdaq Biotechnology 0.34659 51.7 0.85651
iShares Russell 2000 Growth ETF 0.33761 38.04 0.6026
JPMorgan BetaBuilders U.S. Small Cap Equity Fund 0.30479 24.75 1.59225
First Trust Small Cap Core AlphaDEX Fund 0.28692 17.31 1.87983
First Trust Multi-Manager Small Cap Opportunities ETF 0.27344 48.51 0.31756
Vanguard S&P Small-Cap 600 Value ETF 0.25 12.06 2.40883
ProShares Ultra SmallCap600 0.24667 49.8 1.83727
SPDR S&P 600 Small Cap Value ETF 0.23566 11.01 2.34209
BNY Mellon US Small Cap Core Equity ETF 0.23293 30.07 1.75333
First Trust US Equity Opportunities ETF 0.23204 39.99 0.69524
iShares Morningstar Small-Cap Growth ETF 0.19941 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.19941 587.89 0.72598
Vanguard Russell 2000 ETF 0.18 17.16 1.48801
Syntax Stratified SmallCap ETF 0.15893 13.51 1.639
Fidelity Small-Mid Multifactor ETF 0.15442 32.31 1.59943
iShares MSCI USA Small-Cap Min Vol Factor ETF 0.1494 18.2 1.66828
First Trust Nasdaq BuyWrite Income ETF 0.13262 7.27 0.92977
Schwab U.S. Small-Cap ETF 0.12925 17.47 1.51433
Invesco Russell 2000 Dynamic Multifactor ETF 0.12351 11.14 1.64004
First Trust Multi Cap Growth AlphaDEX Fund 0.11915 41.56 1.02425
Vanguard U.S. Momentum Factor ETF 0.11 30.05 1.05834
SPDR S&P Kensho New Economies Composite ETF 0.10429 21.57 0.88486
VictoryShares US Small Cap Volatility Wtd ETF 0.10182 30.08 1.67818
VictoryShares US Discovery Enhanced Volatility Wtd ETF 0.10149 21.4 1.67826
iShares Morningstar Small-Cap ETF 0.10009 391.25 1.60498
iShares Morningstar Small-Cap ETF 0.10009 30.1 1.60498
ProShares UltraPro Russell2000 0.09866 89.82 1.47873
Timothy Plan US Small Cap Core ETF 0.09547 30.16 1.63049
Goldman Sachs Innovate Equity ETF 0.08413 29.66 1.20987
First Trust Active Factor Small Cap ETF 0.0841 34.25 1.61948
Vanguard Extended Market ETF 0.07 24.2 1.34786
Vanguard Small Cap Value ETF 0.07 17.27 2.19419
Fidelity MSCI Health Care Index ETF 0.0587 3 1.46057
Goldman Sachs ActiveBeta US Small Cap Equity ETF 0.05689 31.36 1.41955
iShares ESG Aware MSCI USA Small-Cap ETF 0.04807 18.09 1.49366
Invesco FTSE RAFI US 1500 Small-Mid ETF 0.02867 17.58 1.75869
ProShares Hedge Replication ETF 0.02777 5.92 1.47892
Dimensional U.S. Core Equity 2 ETF 0.01968 30.76 1.47098
Humankind US Stock ETF 0.01926 18.81 1.99919
FlexShares Morningstar US Market Factor Tilt Index Fund 0.01563 21.94 1.69572
SPDR S&P 1500 Momentum Tilt ETF 0.01375 38.25 1.12176
Dimensional US Core Equity Market ETF 0.01008 30.98 1.40618
Vanguard Russell 3000 ETF 0.01 31.87 1.43817
Vanguard ESG U.S. Stock ETF 0.01 23.54 1.26927
SPDR Portfolio S&P 1500 Composite Stock Market ETF 0.00881 24.29 1.46083
Schwab U.S. Broad Market ETF 0.00878 24.86 1.43354
iShares Russell 3000 ETF 0.00827 24.83 1.43482
Invesco S&P SmallCap 600 Revenue ETF 0.00787 30.92 1.94562
Dimensional U.S. Equity ETF 0.00632 31.53 1.3557
Avantis U.S. Equity ETF 0.00221 23.04 1.59151
SPDR Portfolio MSCI Global Stock Market ETF 0.00004 17.99 2.19607



Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Krish S. Krishnan M.B.A., M.S. Founder, Chairman, President & CEO 1.07M 1965 (60 yıllar)
Ms. Suma M. Krishnan Founder, President of R&D and Director 789.92k 1965 (60 yıllar)
Ms. Kathryn A. Romano Executive VP & Chief Accounting Officer 528.87k 1982 (43 yıl)
Mr. John Karakkal Vice President of North American Sales & Marketing N/A
Mr. Josh Suskin Director of Human Resources & Operations N/A
Mr. Laurent Goux Senior VP & GM of Europe N/A
Mr. John Thomas General Counsel & Corporate Secretary N/A
Ms. Christine Wilson Head of U.S. Sales & Marketing N/A
Dr. Stephane Paquette Ph.D. Vice President of Corporate Development
Mr. David Chien Senior Vice President of Clinical Development

Adres: United States, Pittsburgh. PA, 2100 Wharton Street - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.krystalbio.com